Head and Neck Cancer Trial, Recruiting NCT07318220 Sponsor: University of Miami Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT07318220
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 80 years old
  • People diagnosed with a specific type of head and neck cancer (squamous cell carcinoma) that has not spread to other parts of the body, originating in areas such as the mouth, throat, voice box, or nasal passages
  • People whose treatment plan includes radiation therapy or a combination of chemotherapy and radiation therapy aimed at curing the cancer (people who have already had surgery for their head and neck cancer may still be eligible)
  • People who have been cleared by their medical team to do exercise
  • People whose first treatment is not scheduled to start within the next 3 weeks at the time they are recruited into the study
  • People who speak English or Spanish

Who may not be able to join:

  • People whose cancer has spread (metastasised) to other parts of the body
  • People who are unable to complete the initial assessments or begin the pre-treatment program before their radiation or chemoradiation treatment starts
  • People for whom a doctor has determined that changes to diet or physical exercise would be unsafe
  • People who do not speak English or Spanish
  • People with a history of dementia or a major psychiatric condition that could interfere with taking part in the study
  • People who have had a stroke, heart attack, or heart failure within the past year
  • People whose overall physical functioning is assessed by their medical team as significantly limited (confirm with trial site regarding the specific scoring scale used)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Akina Natori, MD, MSPH, University of Miami

Phone: (305) 243-6005

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 May 2026
Est. completion
30 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Aim 2: Feasibility of Participant Engagement in Prehabilitation Prescription Program; Aim 2: Feasibility of Participant Attendance to Scheduled Visits of the Prehabilitation Prescription Protocol; Aim 2: Acceptability of Participants That Feel Satisfied with the Prehabilitation Prescription Protocol

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov